Nuzenio

Yahoo Finance Silexion

Yahoo Finance Silexion entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 2 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Silexion Therapeutics Reports New Positive Preclinical Findings Demonstrating Multi-Mechanism Immune Sensitization by SIL204 in KRAS-Driven Cancers - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 13:15:00 GMTSilexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTSilexion Therapeutics Initiates Phase 2/3 Trial of SIL204 in Pancreatic Cancer - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Tue, 04 Aug 2026 13:15:00 GMTSilexion Therapeutics Reports New Positive Preclinical Findings Demonstrating Multi-Mechanism Immune Sensitization by SIL204 in KRAS-Driven Cancers - Yahoo Finance
Wed, 29 Jul 2026 07:00:00 GMTSilexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center - Yahoo Finance
Wed, 29 Jul 2026 07:00:00 GMTSilexion Therapeutics Initiates Phase 2/3 Trial of SIL204 in Pancreatic Cancer - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Yahoo Finance Silexion.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.